THINK Surgical, a U.S.-based developer of orthopedic robots, has won the 2024 Medical Device Excellence Awards in the Innovation and Product Launches categories for its innovative approach to orthopedic surgery.
The Medical Device Network Excellence Awards celebrate the greatest achievements and innovations in the medical devices industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies that are driving change in the industry.
Go deeper with GlobalData
THINK Surgical won the Innovation award for its TMINI® Miniature Robotic System, a first-of-its-kind miniature, handheld, wireless robot that enhances the precision and efficiency of orthopedic surgery. The Product Launches award was secured for the strategic and successful introduction of the TMINI System, which demonstrated adaptability and market demand by rapidly expanding its Implant Data Hub (ID-HUB™) and securing key partnerships within a tight regulatory timeline.
Advancements in robotic knee surgery
THINK Surgical’s TMINI Miniature Robotic System represents a significant leap forward in robotic knee surgery. The system’s miniature, handheld, wireless design is a first in the U.S. market, providing a level of maneuverability and ease of use that traditional, larger robotic systems cannot match. The design allows surgeons to maintain the tactile feedback they rely on during procedures while benefiting from the precision of robotic assistance.
The proprietary 6-camera overhead active tracking system is a technological breakthrough that enhances the TMINI System’s functionality. By reducing ‘line of sight’ issues, surgeons can maintain focus on the procedure without worrying about obstructions that could interfere with the robot’s tracking capabilities. The system continuously and accurately monitors surgical instruments, which is critical for achieving the desired outcomes in knee surgery.
The TMINI PRO™ Workflow is another cornerstone of the system’s innovation. It provides surgeons with the ability to make intraoperative adjustments, offering real-time feedback and the flexibility to refine implant positioning during the surgery. The adaptability of the system is crucial for addressing the unique anatomical needs of each patient, leading to better stability and fit of the knee implant.
Furthermore, the TMINI System’s open implant platform is a strategic advantage that allows surgeons to select from the most extensive range of implant systems and design philosophies currently available in the U.S. This open approach contrasts with closed systems that limit surgeons to specific implant brands, thus fostering a more patient-centric approach to surgery.
Strategic product launch: The TMINI Miniature Robotic System
The strategic launch of the TMINI System was executed with precision, mirroring the system’s own operational accuracy. THINK Surgical successfully navigated the complex landscape of regulatory clearances, securing an initial FDA 510(k) clearance in May 2023 for use with a single implant partner. This milestone was quickly followed by the first use of the system in September 2023, and subsequent special 510(k) clearances that expanded the number of compatible implant partners to six by August 2024.
The collaboration with Zimmer Biomet in June 2024 marked a significant expansion of the system’s reach, further demonstrating THINK Surgical’s commitment to establishing strong industry partnerships. The release of the TMINI System version 1.1 in July 2024 included a software update that introduced substantial enhancements, showcasing the company’s dedication to continuous improvement and innovation.
The rapid expansion of the Implant Data Hub (ID-HUB) to include multiple implant partners reflects THINK Surgical’s adaptability and responsiveness to market needs. By designing a system that meets the requirements of both high-volume hospitals and outpatient surgery centers, THINK Surgical has effectively broadened its market reach. The company’s proactive engagement with the medical community for clinical validation and peer endorsement has been evident through its collaborations and presentations at medical conferences, further solidifying the TMINI System’s standing in the medical community.
THINK Surgical’s TMINI Miniature Robotic System is, thus, a testament to the company’s commitment to advancing orthopedic surgery through innovation, precision, and adaptability. The Innovation and Product Launches awards acknowledge the company’s efforts to enhance surgical outcomes.
“We are honored to receive these two awards from the Medical Device Network. To have the TMINI® Miniature Robotic System recognized in both the Innovation and the Knee categories is humbling. THINK Surgical has a strong commitment to innovation and commercial excellence. These awards are only possible thanks to the talented employees and passionate culture in our company.” – Stuart Simpson, President and CEO of THINK Surgical Inc.
Company Profile
THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots. THINK Surgical robots are open platforms providing support for implant brands from multiple manufacturers, enabling the choice of implant to be driven by the surgeon.
THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology. Please refer to the instructions for use for the TMINI Miniature Robotic System for a complete list of indications, contraindications, warnings, and precautions. For additional product information, please visit www.thinksurgical.com
, THINK Surgical, Thought provoking technology, TMINI, TMINI PRO and ID-HUB are trademarks of THINK Surgical, Inc.
MKG-24-69 Rev01
Contact Details
Nick Margree, Chief Growth Officer
E-mail: nmargree@thinksurgical.com
Links:
Website: https://thinksurgical.com/
